Gregg Beloff serves as Executive at Pandion Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Gregg Beloff has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Apr 1, 2021 involved transacting 13,196 shares valued at $791.8K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Apr 1, 2021 | PAND | $791.8K | Tender | 13,196 | $60.00 | Discretionary |
Gregg Beloff currently holds 0 shares of Pandion Therapeutics, Inc. (PAND), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gregg Beloff has been a net neutral trader of PAND stock. They have purchased $0 and sold $0 worth of shares.
Gregg Beloff's most recent insider trade was on Apr 1, 2021, when they sold 13,196 shares at $60.00 per share.
Get notified when new Form 4 filings are submitted